Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
TN8.DE
HOLDThermo Fisher Scientific Inc. · Healthcare · United States · $187.1B · Avg Vol: $701K/d
COMPANY DESCRIPTION
Thermo Fisher Scientific Inc. is the global leader in serving science, providing analytical instruments, laboratory equipment, diagnostics, and life sciences consumables. The company's moat is built on its unmatched scale, comprehensive product portfolio, and high customer switching costs within research and clinical laboratories. It operates as a highly consolidated, vertically integrated giant in the life sciences tools industry.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 44.9B | 42.9B | 42.9B | 44.6B | -0.3% | 45.2B | 47.8B | 50.3B | 6.2% |
| EPS | 17.75 | 15.52 | 16.58 | 17.77 | 0.0% | 18.19 | — | — | — |
| Shares | 390.5M | 386.6M | 380.8M | 376.2M | -3.7% | 371.6M | — | — | — |
| Debt | 34.5B | 34.9B | 31.3B | 39.4B | 4.5% | 43.2B | — | — | — |
| Equity | 44.0B | 46.7B | 49.6B | 53.4B | 6.7% | — | — | — | — |
| Op CF | 9.2B | 8.4B | 8.7B | 7.8B | -5.1% | 8.3B | — | — | — |
| Inv CF | -2.2B | -5.1B | -5.8B | -4.0B | — | — | — | — | — |
| Fin CF | -2.8B | -3.6B | -6.8B | 1.8B | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of TN8.DE are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| TN8.DE | Thermo Fisher Scientific Inc.(you) | $187.1B | 62 | HOLD |
| DHR | Danaher Corporation | $134.6B | 57 | HOLD |
| IDXX | IDEXX Laboratories, Inc. | $42.9B | 59 | HOLD |
| WAT | Waters Corporation | $36.8B | 65 | BUY |
| IQV | IQVIA Holdings Inc. | $34.7B | 67 | BUY |
| NTRA | Natera, Inc. | $37.5B | 52 | HOLD |
| LONN.SW | Lonza Group AG | $46.1B | 44 | HOLD |
| A | Agilent Technologies, Inc. | $32.5B | 77 | BUY |
| ERF.PA | Eurofins Scientific SE | $13.6B | 65 | HOLD |
| MTD | Mettler-Toledo International Inc. | $26.8B | 79 | BUY |
Peer medians: ROE 2.1% · P/E 23.4x · Gross margin 50.2%